Cargando…
Pan-Cancer Study on Protein Kinase C Family as a Potential Biomarker for the Tumors Immune Landscape and the Response to Immunotherapy
The protein kinase C (PKC) family has been described with its role in some cancers, either as a promoter or suppressor. PKC signaling also regulates a molecular switch between transactivation and transrepression activity of the peroxisome proliferator-activated receptor alpha (PPARalpha). However, t...
Autores principales: | Abdelatty, Alaa, Sun, Qi, Hu, Junhong, Wu, Fubing, Wei, Guanqun, Xu, Haojun, Zhou, Guoren, Wang, Xiaoming, Xia, Hongping, Lan, Linhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841516/ https://www.ncbi.nlm.nih.gov/pubmed/35174160 http://dx.doi.org/10.3389/fcell.2021.798319 |
Ejemplares similares
-
The Pan-Cancer Crosstalk Between the EFNA Family and Tumor Microenvironment for Prognosis and Immunotherapy of Gastric Cancer
por: Xie, Rongrong, et al.
Publicado: (2022) -
Multi-Omics Analysis of MCM2 as a Promising Biomarker in Pan-Cancer
por: Yuan, Jing, et al.
Publicado: (2022) -
STK39 is a novel kinase contributing to the progression of hepatocellular carcinoma by the PLK1/ERK signaling pathway
por: Zhang, Chengfei, et al.
Publicado: (2021) -
Pan-cancer analysis of the angiotensin II receptor-associated protein as a prognostic and immunological gene predicting immunotherapy responses in pan-cancer
por: Hong, Kai, et al.
Publicado: (2022) -
Oncogenic Landscape of Somatic Mutations Perturbing Pan-Cancer lncRNA-ceRNA Regulation
por: Zhang, Yuanfu, et al.
Publicado: (2021)